Scientific Advisory Board
Dr. Ross Cagan
Regius Chair of Precision Medicine, University of Glasgow. Formerly, Icahn School of Medicine and Director of Center of Personalised Cancer Therapeutics, Mount Sinai, where he developed PDP methodology.
Scientific Advisory Board
Dr. Marshall Posner
Director of the Center for Personalised Cancer Therapeutics at Mount Sinai and Co-Leader of the Cancer Clinical Investigation Program for The Tisch Cancer Institute.
Consultant Medical Oncologist
Dr Daniel Krell
Consultant Medical Oncologist, Royal Free Private, HCA/LOC Harley St, London. Focus on GI cancers and expertise in molecular drivers of cancer.
Medical Advisory Board
Dr. Jordan Shlain
Founder & Chairman of Private Medical, a full-service Family Office for Health and Medicine, utilizing innovations in digital health, precision diagnostics and personalized therapeutics and serving members in New York, San Francisco, Silicon Valley, Beverly Hills, Santa Monica & Miami since 2002. Founder of one of the first AI digital health companies, Healthloop. Lectured at Princeton, Columbia, UC Berkeley and Stanford.
Medical Advisory Board
Prof. Gary Middleton
Professor of Medical Oncology, Institute of Immunology and Immunotherapy, University pf Birmingham. Gary sits on the Lung CSG, the NCRI advanced colorectal sub-group, the NCRI pancreatic sub-group and CTAAC.
Medical Advisory Board
Dr. Sanjay Juneja
Hematologist & Medical Oncologist. Social & News Media Personality and host of 'Target: Cancer Podcast'. Sits on the editorial board of AI in Precision Oncology Journal. Co-Founder of Medfluencers.
Medical Advisory Board
Dr. Jonas Feilchenfeldt
Consultant in Medical Oncology, core faculty member ESO, Service d'Oncologie Medical, Rivera-Chablis Hospital, Switzerland
Medical Advisory Board
Dr. Michael Castro
Neuro & Medical Oncologist, Beverly Hills Cancer. Recognised as one of TopDoctors in America by IS News & World Report.
Medical Advisory Board
Dr. Mehra Golshan
Deputy Chief Medical Officer, Director Breast Program, Chief of Breast Surgery, Yale Cancer Center, Smilow Cancer Hospital. Professor of Surgery, Yale School of Medicine.
Medical Advisory Board
Dr. Andrew Gaya
Consultant Clinical Oncologist, The Cromwell Hospital, The London Clinic and GenesisCare. Specialising in the treatment of Gastrointestinal Cancer. A leading authority on the unique combination of multiple treatment modalities and personalised tumour molecular profiling.
Medical Advisory Board
Dr. Elizabeth Smyth
Clinical Consultant, gastrointestinal oncology, Addenbrooke's Hospital, Cambridge.
Scientific Advisory Board
Michael Elashoff
Head of Data Science at Project Ronin. Developed the algorithms behind two validated genomic diagnostic tests (Celmatix, CardioDX).
Advisory Board
Dr Niti Pall
Medical Director to KPMG's Global Health Practice. Senior Advisor to AXA. Formerly Medical and Innovation Director of Emerging Markets for BUPA.
